News / Blog
New Year holidays Schedule
Catalog
Dexamethasone ointment 0.1% (corticosteroid)
Product Code :
Availability : 12
USD 25.00
General information on Japanese Dexamethasone ointment 0.1% (corticosteroid)
Package details: 10 tubes * 5 g each
Manufacturer: Iwaki Seiyaku Co. Ltd., Japan
Active ingredient: dexamethasone (chemical formula C22H29FO5)
Medical effect: dexamethasone ointment is effective for the treatment of:
- eczema,
- dermatitis,
- skin allergic reactions,
- rash,
- pruritus cutis,
- insect bites,
- psoriasis.
Contraindications and precautions: do not use in patients with bacterial, fungal or viral skin infections, dermatitis of the ear canal, ulcers, burns or frostbites. Do not apply the ointment after the after-shaving lotion or make up. Do not use in pregnant or breastfeeding women. If an allergic reaction occurs, stop using the medication and consult with your doctor. If you’re taking any other medication, please consult with your doctor before use.
Dosage and administration of Dexamethasone ointment 0.1% from Japan (corticosteroid)
Apply on clean dry skin 2-3 times a day. Do not use the medication longer than prescribed as it may cause adverse effects. Avoid getting into your eyes.
How effective is Dexamethasone ointment 0.1% from Japan (corticosteroid)?
Dexamethasone is a synthetic pregnane corticosteroid and derivative of hydrocortisone. It works as an agonist of the glucocorticoid receptor. Dexamethasone narrows blood vessels, provides anti-inflammatory effect and reduces swelling, redness and itching.
Who should use Dexamethasone ointment 0.1% from Japan?
Dexamethasone ointment is effective against eczema or dermatitis, skin allergic reactions, rash, pruritus cutis, insect bites and psoriasis. Studies also show that dexamethasone can help even the patients with a history of failure in topical treatment of psoriasis and atopic dermatitis (L. Hogue, L. A. Cardwell et al. Psoriasis and Atopic Dermatitis "Resistant" to Topical Treatment Responds Rapidly to Topical Desoximetasone Spray. Journal of Cutaneous Medicine and Surgery, 2019 Mar/Apr; 23(2): 157-163).